Education
About Us
Working with TipRanks
Follow Us
Vicore Pharma Holding AB (SE:VICO)
:VICO
VICO Stock Chart & Stats
kr11.28
-kr0.08(-1.06%)
At close: 4:00 PM EST
kr11.28
-kr0.08(-1.06%)
Day’s Range― - ―
52-Week Rangekr6.09 - kr14.10
Previous CloseN/A
Volume158.42K
Average Volume (3M)757.43K
Market Cap
kr2.63B
Enterprise Valuekr848.20M
Total Cash (Recent Filing)kr936.98M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta0.57
Next Earnings
Nov 05, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.49
Shares Outstanding234,609,770
10 Day Avg. Volume456,327
30 Day Avg. Volume757,427
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Vicore Pharma Holding AB News
VICO FAQ
What was Vicore Pharma Holding AB’s price range in the past 12 months?
Vicore Pharma Holding AB lowest stock price was kr6.09 and its highest was kr14.10 in the past 12 months.
What is Vicore Pharma Holding AB’s market cap?
Vicore Pharma Holding AB’s market cap is kr2.63B.
When is Vicore Pharma Holding AB’s upcoming earnings report date?
Vicore Pharma Holding AB’s upcoming earnings report date is Nov 05, 2025 which is in 4 days.
How were Vicore Pharma Holding AB’s earnings last quarter?
Vicore Pharma Holding AB released its earnings results on Aug 22, 2025. The company reported -kr0.492 earnings per share for the quarter, missing the consensus estimate of -kr0.46 by -kr0.032.
Is Vicore Pharma Holding AB overvalued?
According to Wall Street analysts Vicore Pharma Holding AB’s price is currently Overvalued.
Does Vicore Pharma Holding AB pay dividends?
Vicore Pharma Holding AB does not currently pay dividends.
What is Vicore Pharma Holding AB’s EPS estimate?
Vicore Pharma Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vicore Pharma Holding AB have?
Vicore Pharma Holding AB has 234,609,770 shares outstanding.
What happened to Vicore Pharma Holding AB’s price movement after its last earnings report?
Vicore Pharma Holding AB reported an EPS of -kr0.492 in its last earnings report, missing expectations of -kr0.46. Following the earnings report the stock price went up 3.166%.
Which hedge fund is a major shareholder of Vicore Pharma Holding AB?
Currently, no hedge funds are holding shares in SE:VICO
Company Description
Vicore Pharma Holding AB
Vicore Pharma Holding AB (VICO) is a Sweden-based pharmaceutical company focused on the development of innovative therapies for rare lung diseases and related indications. The company's core products are centered around its proprietary angiotensin II type 2 receptor (AT2R) agonist platform, which aims to address unmet medical needs in pulmonary and fibrotic diseases. Vicore Pharma's lead product candidate, VP01 (C21), is being developed for conditions such as idiopathic pulmonary fibrosis (IPF) and COVID-19-induced acute respiratory distress syndrome (ARDS).
Technical Analysis
Hansa Biopharma AB
―
BioInvent International AB
―
SynAct Pharma AB
―
Xspray Pharma AB
―
Cantargia AB
―
Options Prices
Currently, No data available
---